Whilst the burden of human sleeping sickness has been reduced by more than 95%, Nagana – caused by different species of trypanosomes- continues to undermine livestock productivity across vast swathes of Africa. Recognising this challenge, Food and Agriculture Organization (FAO), in collaboration with multiple partners, has developed a Progressive Control Pathway (PCP) to address key barriers […]

We’re excited to share GALVmed’s 2024 Year in Review. From product and market development to strategic partnerships and regulatory progress, this comprehensive report highlights the milestones and achievements that shaped our year. We are grateful to our partners and stakeholders for their continued and invaluable support. Read it here.   Cover photo credit: FAO/Luis Tato

GALVmed is excited to announce the search for a new Chief Executive Officer as current CEO, Carolin Schumacher, prepares to step down later this year after providing exceptional leadership and dedication that have been instrumental to GALVmed’s success and impact. The incoming CEO will lead the organisation into its next chapter and will build upon […]

The control of Foot and Mouth Disease (FMD) in the Eastern Africa Region is now a step closer thanks to a newly registered first ever quadrivalent FMD vaccine tailored for region. As one of the most infectious livestock diseases in the world, Foot and Mouth Disease (FMD) presents a constant global threat to animal trade […]

In a world of significant technology advancements, data is becoming increasingly important. Data serves as the foundation for machine learning models to identify trends and patterns, which is often used to make decisions. In animal health, data can be used to improve efficiency and profitability of value chain actors based on sound, evidence-based decisions. “There […]

We are pleased to present GALVmed’s Year in Review for 2023. This comprehensive report summarises the accomplishments and milestones that shaped the course of our journey and endeavours over the past year. From product and market development to critical partnerships and regulatory advancements, this report reflects our team’s dedication and collective efforts, contributing to the […]

GALVmed and Elanco Animal Health will convene stakeholders on sustainable tick control and acaricide management in Kampala, Uganda. The event which will be held on the December 6 and 7, 2023, will bring together participants closely working on animal health including representatives from Uganda government agencies, dairy sectors, veterinarians and paravets, academia, finance, NGOs and […]

News originally published by S&P Global Multiple partners have created a taskforce to tackle African animal trypanosomiasis. S&P Global’s head of animal health Joseph Harvey spoke to GALVmed’s AAT development program manager Michael Pearce to garner more details about this new alliance. A new collaboration has brought together partners from industry, academia and government to […]

GALVmed is pleased to announce the appointment of Dr Karelle de Luca as Head of Research & Development, effective August 27th, 2023. Dr de Luca is a researcher with deep knowledge, expertise and connections in the fields of immunology & vaccinology. Curious and determined to make a tangible difference through her work, she comes to […]

On July 12, the PREVENT project launched a Hatchery Field Technicians training programme in Rwanda as part of its activities and efforts to establish an innovative veterinary health platform in Africa through medium-size hatchery vaccination. Since its inception in 2021, PREVENT is collaborating with various medium-sized hatcheries across 8 countries in Africa to provide high-quality, […]